English version Polska wersja
 

Read-Gene - Innovative Genetics

READ-GENE SA is a company of innovative technologies, which aim is to commercialize methods of detection, prevention and treatment of the most common types of malignant tumours.
 
1 2 3
 
 

Co-operation

selvita kcr adamed

We are associated partner in the Eco4Life project. More...

Company structure

Incorporated as a joint-stock (SA) company under Polish law, READ-GENE intends to act globally from its inception. Its operational headquarters are in Szczecin.

CEO - Professor Jan Lubinski

Prof. Jan Lubinski is one of the most famous geneticists / oncologists in Poland. He is the founder and the head of International Hereditary Cancer in Szczecin. Prof. Lubinski’s research interests are in the area of clinical genetics of cancer. Professor Lubinski holds a PhD from the Pomeranian Medical University in Szczecin. He was a visiting scientist at Pasteur Institute in Paris, at the Wistar Institute and at the Jefferson Cancer Institute in Philadelphia. In 1996 he was promoted to Associate Professor at the Pomeranian Medical University in Szczecin. In 1997 he became a member of an Expert Board in Europe and Africa within the framework of "Familial Cancer and Prevention" International Union Against Cancer (UICC) programme. Prof. Lubinski is the author of around 200 papers on clinical and molecular genetics of cancers and the author and coordinator of a few EU projects (“Development of Polish Network of Hereditary Cancer Centres”, “Development of Cancer Family Syndrome Registries in Eastern Europe”). J. Lubinski is the editor of a journal published under auspices of UICC – “Hereditary Cancer in Clinical Practice”. In years 1 998 - 2011 the Polish National Consultant of Clinical Genetics. He also serves as a member of the Biotechnology Committee of the Polish Academy of Sciences and Human Genetics and the Molecular Pathology Committee of Polish Academy of Sciences. He was the organizer of a screening examination program in the area of hereditary cancer detection for people in Zachodniopomorskie Region of Poland encompassing a population of 1.5 million. In years 2006 - 2011 he is a member of a board of European Society of Human Genetics. Prof. Lubinski is also a member of the Scientific Advisory Board of a Polish biotechnology companies: Clinical Research Organisation – KCR biotechnology - Selvita. Since 2010 member of Scientific Council of National Centre for Research and Development.
Professor Jan Lubinski achievements.

 

Board of Directors (all Directors are independent)